• Budesonide in Reliable Cell Assays

  2026-09-10

  This scenario-driven guide shows how Budesonide, SKU B1900, can support more interpretable viability, proliferation, and airway inflammation experiments. It connects formulation control, exposure modeling, vehicle matching, and vendor selection with evidence from a recent pulmonary permeability study.

• From Mechanism to Signal: Smarter ECL Translation

  2026-09-10

  Translational protein biology depends on more than discovering a pathway: researchers must convert mechanistic hypotheses into reproducible, decision-ready measurements. This article connects the TLR4/NF-κB findings of a Sanghuangporus vaninii hetero-galactan study with practical strategy for sensitive immunoblotting and low-abundance protein validation.

• AIBP-LRP2–HDL Axis in Collateral Circulation

  2026-09-09

  Zhu et al. identify an AIBP-LRP2–HDL–miR-223 pathway that restrains CXCR4+ stemlike capillary endothelial cells during collateral vessel formation. The study links lipid handling to a two-phase remodeling program in which capillary cells expand before adopting arterial characteristics, offering a mechanistic framework for ischemic revascularization research.

• SR 11302 AP-1 Inhibitor: Cancer Assay Workflows

  2026-09-09

  SR 11302 provides a retinoid-independent route to suppress AP-1 signaling in tumor-cell and tumor-microenvironment studies. This practical guide connects dose-controlled proliferation assays with macrophage-polarization workflows inspired by recent colitis-associated colorectal cancer research.

• 2-APB: Reliable Calcium-Linked Cell Assays

  2026-09-08

  A scenario-based guide to using 2-APB (2-aminoethoxydiphenyl borate), SKU B6643, in viability, proliferation, cytotoxicity, and calcium-signaling workflows. It explains concentration selection, solvent controls, SOCE interpretation, and practical product-selection criteria using documented formulation and activity data.

• Taltirelin Acetate: Applied Research Workflows

  2026-09-07

  Taltirelin acetate connects TRHR1 pharmacology with practical models of itch, dopaminergic dysfunction, neuroprotection, sleep-related biology, and oral formulation performance. This workflow-led guide translates published mouse findings into assay controls, dosing decisions, and troubleshooting steps without overstating translational evidence.

• Modified Ethanol Injection for mRNA Lipoplexes

  2026-09-07

  Tang and colleagues adapted a modified ethanol injection method from siRNA delivery to the preparation of mRNA lipoplexes and screened 18 lipid combinations. Formulations containing DC-1-16 or TC-1-12 with DOPE and PEG-Chol produced strong protein expression, while the DC-1-16 formulation also supported expression in mouse lungs and spleen and generated antigen-specific IgG1 after immunization.

• CCG-1423 and the Translational RhoA Signal

  2026-09-05

  RhoA signaling is increasingly understood as a systems-level regulator of cytoskeletal tension, transcription, barrier integrity, invasion, and cell survival. This thought-leadership article examines how CCG-1423, a mechanistically distinct RhoA inhibitor, can help translational researchers connect MRTF-A nuclear import with the RhoA/ROCK signaling pathway while framing a cautious, testable bridge to recent findings on Minute Virus of Canines infection.

• Sulfo-Cy3 NHS Ester for Vascular Protein Labeling

  2026-09-04

  Sulfo-Cy3 NHS Ester combines water compatibility with amine-selective labeling, making it a practical choice for tracking difficult proteins in ischemia and endothelial-cell assays. This guide connects the dye to the AIBP–LRP2–HDL–miR-223 mechanism while providing executable conjugation, purification, and troubleshooting strategies.

• Arachidonic Acid and Rapid Vaccine Immunity

  2026-09-04

  A 2025 EMBO Molecular Medicine study shows that dietary arachidonic acid can accelerate and strengthen rabies vaccine-induced neutralizing antibody responses in mice and human volunteers. The work links arachidonic acid enrichment in lymph nodes to prostaglandin I2–cAMP–PKA signaling, CD86 induction, and activation-induced cytidine deaminase activity in B cells, suggesting a dietary route to improve germinal-center responses.

• GDC-0994: From ERK Signaling to Causal Assays

  2026-09-03

  GDC-0994 is a selective ERK1/2 inhibitor for testing how MAP kinase signaling drives cancer phenotypes and cholestatic injury. This article translates a zebrafish mechanistic study into a cross-domain assay strategy that separates upstream estrogenic triggers from ERK-dependent effects.

• Lisinopril dihydrate ACE Inhibitor Workflows

  2026-09-03

  Build more reproducible ACE inhibition assays and disease models with a practical workflow for Lisinopril dihydrate. The guide combines solution-preparation controls, physiologic readouts, peptidase counter-screening, and troubleshooting for hypertension research, heart failure research, and renal studies.

• Eicosapentaenoic Acid (EPA): Mechanisms & Research

  2026-09-02

  Eicosapentaenoic Acid is an EPA omega-3 fatty acid used to study membrane lipid remodeling, lipid oxidation, inflammation, and vascular biology. The B3464 material is a research-grade EPA preparation with supplier-reported purity of approximately 98–99%, while its concentration-dependent assay effects should not be interpreted as clinical efficacy.

• Cy3 Rabbit Anti-Goat IgG (H+L) Antibody Guide

  2026-09-02

  Cy3 Rabbit Anti-Goat IgG (H+L) Antibody provides fluorescent detection of goat IgG primary antibodies in ICC/IF, tissue staining, flow cytometry, and compatible ELISA workflows. It should not be used as a universal secondary antibody, with non-goat primary antibodies, or in enzyme-substrate ELISA without separate validation.

• Bufalin Targets STK33 in Triple-Negative Breast Cancer

  2026-09-01

  The 2025 Advanced Science study identifies serine/threonine kinase 33 (STK33) as a direct binding partner and putative degradation target of Bufalin in triple-negative breast cancer. Through chemical-proteomic screening, biochemical validation, genetic perturbation, animal models, and patient-derived organoids, the authors connect STK33 loss to disruption of the CCAR1 tumor-promoting axis.

8547 records 1/570 page Next 12345 下5页 Last page